Alzheimer's immunotherapy represents a promising frontier in the treatment of Alzheimer’s Disease and dementia. Unlike traditional approaches that focus on managing symptoms, immunotherapy aims to target the underlying causes, such as amyloid plaques or tau proteins, which are characteristic of these neurodegenerative conditions. This innovative treatment leverages the body's immune system to either clear these harmful substances or prevent their buildup in the brain, thereby potentially halting or slowing disease progression.
Recent advancements in research have led to the development of monoclonal antibodies and vaccines designed to stimulate the immune response against Alzheimer’s-related proteins. While challenges remain, such as ensuring safety and effectiveness in human trials and addressing the complexity of the brain's immune responses, ongoing studies offer hope for breakthroughs in combating Alzheimer's disease. Immunotherapy holds the promise of not only improving cognitive function but also fundamentally altering the trajectory of Alzheimer’s, offering renewed hope to millions affected worldwide.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China